Long-term evaluation of nasal polyposis recurrence: a focus on multiple relapses and nasal cytology

G Riva, M Tavassoli, E Cravero, M Moresco… - American Journal of …, 2022 - Elsevier
Purpose Recurrence of chronic rhinosinusitis with nasal polyps (CRSwNP) is highly
variable, reaching 55–60% of cases. Different results about clinical parameters as …

Long-term evaluation of nasal polyposis recurrence: A focus on multiple relapses and nasal cytology

G Riva, M Tavassoli, E Cravero… - American journal …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose Recurrence of chronic rhinosinusitis with nasal polyps (CRSwNP) is highly
variable, reaching 55-60% of cases. Different results about clinical parameters as …

Long-term evaluation of nasal polyposis recurrence: A focus on multiple relapses and nasal cytology

G Riva, M Tavassoli, E Cravero, M Moresco… - AMERICAN JOURNAL …, 2022 - iris.polito.it
Purpose: Recurrence of chronic rhinosinusitis with nasal polyps (CRSwNP) is highly
variable, reaching 55–60% of cases. Different results about clinical parameters as …

Long-term evaluation of nasal polyposis recurrence: A focus on multiple relapses and nasal cytology

G Riva, M Tavassoli, E Cravero, M Moresco… - AMERICAN JOURNAL …, 2022 - iris.unito.it
Purpose: Recurrence of chronic rhinosinusitis with nasal polyps (CRSwNP) is highly
variable, reaching 55-60% of cases. Different results about clinical parameters as …

[引用][C] Long-term evaluation of nasal polyposis recurrence: A focus on multiple relapses and nasal cytology

G Riva, M Tavassoli, E Cravero, M Moresco… - American Journal of …, 2022 - cir.nii.ac.jp
Long-term evaluation of nasal polyposis recurrence: A focus on multiple relapses and nasal
cytology | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Long-term evaluation of nasal polyposis recurrence: A focus on multiple relapses and nasal cytology.

G Riva, M Tavassoli, E Cravero, M Moresco… - American Journal of …, 2021 - europepmc.org
Purpose Recurrence of chronic rhinosinusitis with nasal polyps (CRSwNP) is highly
variable, reaching 55-60% of cases. Different results about clinical parameters as …